Hua Hong Semiconductor: US Export Restrictions Have Minimal Impact on Mature-Node Growth; Maintain Equal-Weight

Core Conclusion

The US order halting certain equipment shipments to Hua Hong Group is unlikely to materially affect the listed Hua Hong Semiconductor (1347.HK). The restrictions target advanced-node development at HLMC (private), while the listed entity’s Fab 9B remains focused on 40–55nm mature nodes. The stock’s 4.59% decline on the news (vs. HSI +1.68%) overstates the risk. We maintain an Equal-weight rating with an HK$88 target price, implying 19% downside.

Market Underestimation: Overreaction to Restrictions

The market appears to have conflated the restrictions on HLMC’s advanced-node capabilities with Hua Hong Semiconductor’s mature-node expansion. Our industry checks confirm the regulation is narrowly aimed at curbing 7/12nm development—not the 40–55nm nodes that drive Fab 9B. The 4.59% single-day selloff is inconsistent with the negligible operational impact we assess for the listed entity.

Evidence Chain

1. Fab 9B exclusively targets mature nodes, shielding it from the restriction scope.

• Fab 9B’s technology roadmap is 40–55nm, well within the “mature node” category.
• Regulatory intent is to suppress advanced-node capabilities; mature-node capacity expansion is not a primary target.
• Investment implication: No disruption to Fab 9B’s ramp schedule or equipment procurement timelines.

2. HLMC consolidation remains limited to 22/28nm, not advanced nodes.

• Prior analysis explicitly stated that immediate full consolidation of HLMC into Hua Hong is not expected.
• Fab 6 integration, beyond the existing Fab 5, will stay confined to 22/28nm lines—no exposure to 7/12nm.
• Investment implication: The restrictions do not alter the consolidation path or introduce additional capex risk.

3. Mature-node expansion trajectory is intact, supported by strong domestic AI infrastructure demand.

• Base case does not assume Hua Hong builds or integrates HLMC’s 7/12nm capacity.
• Power IC demand from China’s AI infrastructure is a durable tailwind for mature-node foundries like Hua Hong.
• Investment implication: Revenue and profit growth drivers remain unchanged; 2026–2028 EPS estimates are unaffected.

Key Risks

• Escalation of export controls: If restrictions unexpectedly broaden to cover mature-node equipment (40–55nm), Fab 9B expansion could face delays.
• Domestic competitive overbuild: Other Chinese foundries aggressively adding 8-inch or 12-inch mature capacity could erode pricing power and utilisation.
• Fab 9B execution risk: Slower-than-expected ramp or difficulty securing customers at Wuxi would pressure margins.
• Downside demand/pricing risk: If wafer ASP increases fail to materialise or downstream orders soften, earnings momentum would weaken.

Valuation and Trade Implications

Using a residual income model with a 9.2% cost of equity (2.0% risk-free rate, 6% equity risk premium, 1.20 beta), a 16.5% medium-term growth rate (revised up from 15.5%), and a 5.0% terminal growth rate, our base-case target price is HK$88. At the current price of HK$108.10, the stock trades at 58.9x 2026e P/E and 26.6x EV/EBITDA—above our estimate of intrinsic value. We see 19% downside and therefore maintain Equal-weight.

Appendix Data Summary